利国利国国际老牌w66老牌w66

1970-01-01

Improve Independent Innovation in Biomedicine, Boost Innovation Achievement Transformation: YRDCF Hosts Yangtze River Delta Innovation Medicine Science Forum

利国利国国际老牌w66老牌w66(中国区)_利来老牌利国国际老牌w66官网

利国利国国际老牌w66老牌w66(中国区)_利来老牌利国国际老牌w66官网

On October 17, the Yangtze River Delta Innovation Medicine Science Forum took place. The forum was guided by Yangtze River Delta Regional Cooperation Office (YRDRCO) and the Jing'an District People's Government, supported by Shanghai International Group (SIG), hosted by Yangtze River Delta Collaborative Advantageous Industry Fund (YRDCF), and co-organized by Highlight Capital and Pharmaron.

With the theme "Policies guide the development of the medical industry, technologies lead medical innovation and reform, capital boosts medical achievement transformation", the forum invited top medical scientists from around the world to deliver keynote speeches. Ruan Qing, Executive Deputy Director of YRDRCO and Zhang Jun, Deputy Head of Jing'an District, addressed the opening ceremony.

At the forum, Sun Min, Managing Partner of YRDCF; Dr. Yang Hua, Chief Scientist of Pharmaron; Dr. Tong Youzhi, Founder and Chairman of Kintor; Dr. Shou Jianyong, Founder and Chief Scientist of EnnovBio; and Chen Bing, Partner of Highlight Capital participated in a roundtable discussion themed "Innovation Synergy in the Yangtze River Delta", to explore the future development, layout and plan of innovation medicine in the Yangtze River Delta

The forum also discussed topics such as "Opportunities and Challenges of Health China 2030", "Drug Regulation Reform Speeds up New Drug Development in China", "Accuracy and Challenge of Oncotherapy", and "Innovation Synergy of Medicine in the Yangtze River Delta".

网站地图
友情链接:博天堂918  博天堂918  大发平台  凯发一触即发  4188云顶集团  新利18  凯发一触即发  AG九游会  尊龙凯时  AG尊龙凯时  AG真人国际官网  j9九游会  博天堂918  利国国际老牌w66  云顶国际